尽管肝脏移植是治疗肝细胞癌的确认疗法，但目前不为首次治疗运用肝切除术的病人提供肝移植术。
But although liver transplantation is a recognized therapy for hepatocellular carcinoma, it is not currently offered to those who undergo hepatic resection as the first-line therapy, he notes.
补救性供肝移植可用于初期行肝切除术后的反复肝细胞癌发生或肝功能恶化。
Salvage liver transplantation has been performed for recurrent hepatocellular carcinoma (HCC) or deterioration of liver function after primary liver resection.
目的探讨经肝动脉灌注32磷玻璃微球（ 32PGMS）核素内照射治疗手术不能切除的肝细胞癌的疗效。
Objective To investigate the efficacy of internal radiation of 32 P glass microspheres( 32 P GMS) in unresected hepatocellular carcinoma(HCC) via subcutaneous arterial port.
方法运用透射电镜观察经顺铂化疗后缩小切除的肝细胞癌的形态学特征的改变。
Methods The changes of morphological feature of HCC treated by diam- minedichloroplatinum were observed with transmission electron microscope.
《国际肝病》：在肝切除术后，如果有肝细胞癌复发，我们应该怎么做？
HEPATOLOGY DIGEST: What should we do when HCC recurrent after liver resection?
近年来，我国原发性肝细胞癌的发病率有上升的趋势。一百年来，根治性手术切除被公认为肝癌获得根治的最好手段。
The morbidity of primary hepatocellular carcinoma has been increasing in recent years, so it is emergent to perform research work on the prevention and treatment of primary hepatocellular carcinoma.
方法：收集1995—2000年在复旦大学肝癌研究所行手术切除的355例肝细胞癌患者临床病理资料及术后随访资料。
Methods: a retrospective analysis of clinicopathological data of 355 patients with hepatocellular carcinoma who received hepatic resection in our hospital from 1995 to 2000.
方法：收集1995—2000年在复旦大学肝癌研究所行手术切除的355例肝细胞癌患者临床病理资料及术后随访资料。
Methods: a retrospective analysis of clinicopathological data of 355 patients with hepatocellular carcinoma who received hepatic resection in our hospital from 1995 to 2000.
应用推荐